Pharmaceutical policySee also what's at Wikipedia, your library, or elsewhere.
Broader terms:Narrower terms:Used for:- Drug policy
- Drugs and state
- Drugs -- Government policy
- Pharmacy and state
- Pharmacy -- Government policy
- State and drugs
- State and pharmacy
|
Filed under: Pharmaceutical policy
Filed under: Pharmaceutical policy -- United States Prices, Markets, and the Pharmaceutical Revolution (Washington: AEI Press, 2000), by John E. Calfee (PDF at AEI) Prescription for the People: An Activist's Guide to Making Medicine Affordable for All (Ithaca, NY and London: ILR Press, c2017), by Fran Quigley (PDF and Epub with commentary at Cornell Open) Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease (Washington: Office of Technology Assessment, 1992), by Alan M. Garber, Ann E. Clarke, Dana P. Goldman, and Michael E. Gluck (PDF files at Princeton)
Filed under: Narcotic laws -- United States -- HistoryFiled under: Drug legalization -- United StatesFiled under: Trials (Narcotic laws) -- United StatesFiled under: Patent medicines -- Law and legislation -- United StatesFiled under: Drugs -- Labeling -- Law and legislation -- United StatesFiled under: Drugs, Nonprescription -- Law and legislation
Filed under: Patent medicines -- Law and legislation -- Developing countries
Filed under: Drugs -- Labeling -- Law and legislation -- Developing countries
Filed under: Older people -- Pharmaceutical assistance -- United States Outpatient Immunosuppressive Drugs Under Medicare (OTA-H-452; 1991), by United States Congress Office of Technology Assessment
Filed under: Pharmacy -- Law and legislation -- Great Britain
Items below (if any) are from related and broader terms.
Filed under: Medical policy
Filed under: Health care reform -- BrazilFiled under: Medical policy -- Canada
Filed under: Health care reform -- CanadaFiled under: Medical policy -- Case studiesFiled under: Medical policy -- EuropeFiled under: Medical policy -- Great BritainFiled under: Medical policy -- SingaporeFiled under: Medical policy -- United States Healthy Communities: New Partnerships for the Future of Public Health (1996), ed. by Michael A. Stoto, Cynthia H. Abel, and Anne Dievler (page images with commentary at NAP) Health Policy and the Disadvantaged (Durham, NC and London: Duke University Press, 1991), ed. by Lawrence D. Brown (page images at HathiTrust) Allied Health Services: Avoiding Crises (1989), by Institute of Medicine (U.S.) (page images with commentary at NAP) The Nation's Physician Workforce: Options for Balancing Supply and Requirements (1996), by Institute of Medicine (U.S.) (HTML with commentary at NAP) Clinical Practice Guidelines: Directions for a New Program (1990), ed. by Marilyn J. Field and Kathleen N. Lohr (page images with commentary at NAP) The Artificial Heart: Cost, Risk, and Benefits (1982), by Deborah P. Lubeck and John P. Bunker (PDF files at Princeton) The Swine Flu Affair: Decision-Making on a Slippery Disease (Washington: U. S. Dept. of Health, Education, and Welfare, 1978), by Richard E. Neustadt and Harvey V. Fineberg, contrib. by Joseph A. Califano (page images at HathiTrust) Identifying Health Technologies That Work: Searching for Evidence (1994), by United States Congress Office of Technology Assessment Neurotoxins, at Home and the Workplace: Report to the Committee on Science and Technology, U.S. House of Representatives, Ninety-Ninth Congress, Second Session (Washington: GPO, 1989), by United States House Committee on Science and Technology (page images at HathiTrust) What, If Any, Should Government's Role Be Regarding Health Care in the United States? Excerpts from the 1992 Harry Singer Foundation Essay Contest, ed. by Margaret Bohannon-Kaplan (HTML at Wayback Machine) Policy Implications of the Computed Tomography (CT) Scanner: An Update (1981), by United States Congress Office of Technology Assessment Policy Implications of the Computed Tomography (CT) Scanner (1978), by United States Congress Office of Technology Assessment Policy Implications of Medical Information Systems (OTA-H-56; 1977), by United States Congress Office of Technology Assessment HIV and the Blood Supply: An Analysis of Crisis Decisionmaking (Washington: National Academy Press, 1995), ed. by Lauren B. Leveton, Harold J. Sox, and Michael A. Stoto (page images with commentary at NAP) Headline News, Science Views II (1993), ed. by David Jarmul (page images with commentary at NAP) Headline News, Science Views (1991), ed. by David Jarmul (page images with commentary at NAP) Medical Technology Under Proposals To Increase Competition in Health Care (1982), by United States Congress Office of Technology Assessment The Implications of Cost-Effectiveness Analysis of Medical Technology (1980), by United States Congress Office of Technology Assessment Responding to Health Needs and Scientific Opportunity: The Organizational Structure of the National Institutes of Health, by Institute of Medicine (U.S.) (page images with commentary at NAP) National Priorities for the Assessment of Clinical Conditions and Medical Technologies, ed. by Marielena Lara and Clifford Goodman (page images with commentary at NAP) Taking a Stand on Health Care, by Helen P. Rogers (HTML at Wayback Machine) Filed under: Health care rationingFiled under: Health planningFiled under: National health services
Filed under: DrugsMore items available under broader and related terms at left. |